August 01, 2014 12:34 PM ET

Biotechnology

Company Overview of Talima Therapeutics, Inc.

Executive Profile

Edward F. Schnipper M.D.

Chief Medical Officer, BIND Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships
65--

Background

Dr. Edward F. Schnipper, also known as Ed, M.D., has been the Chief Medical Officer of BIND Therapeutics, Inc. since January 6, 2014. Dr. Schnipper serves as a Managing Director and Chief Medical Officer at Velocity Pharmaceutical Development. Dr. Schnipper served as an Advisor of BIND Therapeutics, Inc. and previously served as its Chief Medical Officer until April 5, 2013. He served as President of Progen Pharmaceuticals, Inc. (formerly CellGate Inc.,) since July 2002. ...

Corporate Headquarters

2255 Martin Avenue
Santa Clara, California 95050

United States

Phone: 650-331-7246
Fax: 650-618-1448

Board Members Memberships

Chief Executive Officer, President and Director
Director

Education

BS
Hobart & William Smith Colleges
MD
Georgetown University School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Talima Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.